Michael M. Douglas
Papers
1
Total Citations
3
H-Index
1
About
Michael M. Douglas is a clinical researcher whose work centers on perioperative pain management and opioid-sparing strategies in urologic surgery. His most cited study, a 2023 quality improvement investigation, demonstrated the effectiveness of buprenorphine as an alternative to conventional opioids for patients undergoing robotic-assisted laparoscopic prostatectomy. This work directly addresses the critical challenge of reducing perioperative opioid use while maintaining effective pain control, contributing to the broader effort to combat the opioid epidemic through evidence-based multimodal analgesia. Though early in his citation trajectory, Douglas’s research has already garnered attention for its practical, patient-centered approach to surgical recovery. His findings offer a replicable model for integrating buprenorphine into enhanced recovery protocols, potentially reducing opioid-related side effects and long-term dependence risks. By focusing on a high-volume surgical procedure, Douglas provides actionable insights for urologists and anesthesiologists seeking to balance pain relief with safety. His work underscores a growing commitment to quality improvement in surgical care, positioning him as a rising voice in the movement toward safer, more responsible perioperative pain management.
Research Focus
Key Achievements
Top Papers
- 1